Intravascular robotics leader Hansen Medical announced that Will Sutton has been appointed to the newly created position of Chief Operating Officer. Reporting directly to President and CEO Bruce Barclay, Mr. Sutton will manage and oversee the company’s engineering and manufacturing … Continue reading →

PolyMet Mining, which is pursuing an exciting 100%-owned copper-nickel-precious metal deposit up in northern Minnesota’s rich Duluth Complex (just off the end of one of the largest undeveloped non-ferrous deposits on earth), reported some big improvements for the NorthMet project … Continue reading →

Merge Healthcare is a leading provider of clinical systems and innovations that seek to transform healthcare. The company’s enterprise and cloud-based solutions for image-intensive specialties provide access to any image, anytime and anywhere. It also provides health stations, clinical trials … Continue reading →

Leading microRNA-based molecular diagnostics provider Rosetta Genomics announced today that it has received two notices of allowance for Patent Applications 12/661,041 and 12/850,091 from the U.S. Patent and Trademark Office. Titled “microRNAs and Uses Thereof,” 12/661,041 has allowed claims covering … Continue reading →

India Globalization Capital has announced financial results for the third quarter ending Dec. 31, 2012. “We are pleased to report profitability this quarter due to our considerable efforts to realign and focus our equipment, processes and people on the iron … Continue reading →

JetBlue Airways, the digitally-minded airline that makes traveling even easier with the introduction of mobile boarding, today announced that customers in eight of the airline’s largest cities can now download electronic boarding passes onto their cell phones using the newly … Continue reading →

Frontier Communications, a provider of broadband, voice, satellite video, wireless Internet data access, entertainment services, and data security solutions across the United States, announced today that the AV-TEST Institute, an independent supplier of IT Security and Antivirus Research services, recognized … Continue reading →

Catalyst Pharmaceutical Partners has developed a very clear market strategy as a specialty biopharma focusing on the commercialization of orphan prescription drugs in the area of neurological disorder and disease. North American rights to the company’s lead product candidate, Firdapse™, … Continue reading →